Adam Hazourli, Founder of eBiotech.ai and President of Abrévia Inc., with more than 2 decades of experience in the pharmaceutical and biotechnology industries.

Throughout his career, Adam has led GMP compliance, quality systems, validation, regulatory inspections, and digital transformation initiatives for organizations across North America and Europe. His work has focused on helping pharmaceutical companies improve operational excellence while maintaining the highest standards of regulatory compliance.

As the founder of eBiotech.ai, Adam has been at the forefront of applying Artificial Intelligence to regulated pharmaceutical environments, introducing the concept of GMP Intelligence™, an approach that combines AI with human expertise to support quality, compliance, and better decision-making.